Silvercrest Asset Management Group 13F: Cuts CVS Stake by $10M

Silvercrest Trims CVS Position

Silvercrest Asset Management Group reduced its holdings in CVS Health Corporation (NYSE: CVS) during the period, cutting its stake by 11.4% according to a Form 13F filed with the Securities and Exchange Commission. The firm sold 100,438 shares, lowering its total count from 880,186 down to 779,748 shares. That remaining block of stock carried an estimated value of $80.68 million at the close of the reporting window. This adjustment fits alongside several other portfolio tweaks made by the asset manager recently, including reductions in ICU Medical and JBT Marel Corporation.

CVS Stock Price Action

CVS Health Corporation shares recently traded at $103.47 on Saturday, sitting comfortably above the 200-day moving average of $88.12 and the 50-day average of $91.80. The equity has moved within a 52-week range spanning from a low of $69.51 up to a peak of $110.68. The company has a beta of 0.60, meaning its price swings tend to be milder than the broader market.

Analysts Set New Price Targets

Wall Street firms have kept a close eye on the health care provider, with a consensus strong buy rating and a mean price target of $115.48 across 25 analysts. On October 12, 2026, Leerink Partners maintained its outperform rating while adjusting its price target to $112.00 from $119.00. Earlier, on September 3, 2026, UBS kept a buy rating on the shares while lowering its target from $126.00 to $118.00. Argus Research also maintained a buy rating on August 19, 2026, raising its target to $114.00 from $104.00. JP Morgan chimed in on August 12, 2026, keeping an overweight rating and setting a target of $118.00.

Understanding CVS Health Corporation

Headquartered in Woonsocket, Rhode Island, CVS Health Corporation operates as a major health solutions provider across the United States. The enterprise runs health care benefits plans, manages pharmacy benefit programs through its pharmacy services division, and operates retail pharmacy and consumer wellness stores. These segments serve millions of customers, including employers, government plans, and individual consumers.

What's Ahead for CVS Health Corporation

Form 13F reports offer a look back at institutional trading choices from the end of a specific quarter and do not necessarily reflect current day-to-day holdings. Investors can anticipate further updates when the company delivers its next financial results report on November 4, 2026. This review covers reported transaction data only and offers no guidance on future stock performance.